Effectiveness of probabilistic contact tracing in epidemic containment: the role of super-spreaders and transmission path reconstruction
arXiv:2312.00910 · doi:10.1093/pnasnexus/pgae377
Abstract
The recent COVID-19 pandemic underscores the significance of early-stage non-pharmacological intervention strategies. The widespread use of masks and the systematic implementation of contact tracing strategies provide a potentially equally effective and socially less impactful alternative to more conventional approaches, such as large-scale mobility restrictions. However, manual contact tracing faces strong limitations in accessing the network of contacts, and the scalability of currently implemented protocols for smartphone-based digital contact tracing becomes impractical during the rapid expansion phases of the outbreaks, due to the surge in exposure notifications and associated tests. A substantial improvement in digital contact tracing can be obtained through the integration of probabilistic techniques for risk assessment that can more effectively guide the allocation of new diagnostic tests. In this study, we first quantitatively analyze the diagnostic and social costs associated with these containment measures based on contact tracing, employing three state-of-the-art models of SARS-CoV-2 spreading. Our results suggest that probabilistic techniques allow for more effective mitigation at a lower cost. Secondly, our findings reveal a remarkable efficacy of probabilistic contact-tracing techniques in performing backward and multi-step tracing and capturing super-spreading events.
References in corpus (7)
- Evidence of economic segregation from mobility lockdown during COVID-19 epidemic
- Non-pharmaceutical interventions during the COVID-19 pandemic: a rapid review
- PACT: Privacy Sensitive Protocols and Mechanisms for Mobile Contact Tracing
- The challenges of containing SARS-CoV-2 via test-trace-and-isolate
- The effectiveness of backward contact tracing in networks
- Epidemic mitigation by statistical inference from contact tracing data
- COVI White Paper